HOME >> MEDICINE >> NEWS
Study indicates widely-used nutritional supplement does not improve cholesterol levels

A new study suggests that use of the nutritional supplement policosanol does not lower cholesterol levels any more than placebo, apparently contradicting the results of previous studies, according to a study in the May 17 issue of JAMA.

Policosanol is a natural substance produced from the waxy coating of sugar cane. Cuban sugar cane policosanol is sold in more than 40 countries mainly because of its supposed lipid-lowering effects, according to background information in the article. Numerous policosanol products from a variety of sources (sugar cane, wheat germ, rice bran, beeswax) are available over-the-counter and on the Internet in several countries. Advertising emphasizes predominantly its reputed lipid-lowering effects, comparable with statins (prescription medications taken to lower cholesterol). Most of the published scientific literature, more than 80 trials, supporting the beneficial effects of policosanol on lipids has been authored by a single research group from Cuba. One clinical trial from the Netherlands showed wheat germderived policosanol ineffective in lowering total cholesterol and low-density lipoprotein cholesterol (LDL-C), sometimes called "bad" cholesterol.

Heiner K. Berthold, M.D., Ph.D., of the University of Cologne, Germany, and colleagues conducted a study to determine the lipid-lowering effects of policosanol. The multicenter, randomized, double-blind, placebo-controlled, trial included 143 patients with hypercholesterolemia (high cholesterol) or combined hyperlipidemia (excess of fats or lipids in the blood) having baseline LDL-C levels of at least 150 mg/dL and either no or 1 cardiovascular risk factor other than known coronary heart disease, or baseline LDL-C levels of between 150 and 189 mg/dL and 2 or more risk factors. The patients were randomized into 5 groups: 10, 20, 40, or 80 mg/d of policosanol or placebo. The study was conducted from September 2000 to May 2001.

In none of the 5 treatment groups did
'"/>

Contact: Heiner K. Berthold, M.D., Ph.D.
berthold@uni-bonn.de
JAMA and Archives Journals
16-May-2006


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... March 20, 2019 , ... Confluent ... (BRPT-Lake), a physical therapist owned outpatient physical and occupational therapy practice with seven ... Physical Therapy was founded more than 55 years ago, our mission has been ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... Santa Clara County, announced that the National Committee for Quality Assurance (NCQA) has ... of business. NCQA is a private, not-for-profit organization dedicated to improving health care ...
(Date:3/20/2019)... ... March 20, 2019 , ... Many companies are ... for safe clinical testing. , A recent publication in the Journal of Stem ... Inc. that has shown promising results for the reversal of aging. The paper, ...
(Date:3/20/2019)... Ohio (PRWEB) , ... March 20, 2019 , ... ... or back pain from disc herniation's, degenerative disc disease, spinal stenosis, sciatica ... all in one location! , At Advanced Spine Joint and Wellness provider's ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla ... function. This newly granted patent, along with 7 clinical studies on Crominex®3+, establish ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... ... which lung cancer patients will respond to chemotherapy, according to a new study ... typically the first-line treatment of advanced-stage non–small cell lung cancer (NSCLC). However, only ...
(Date:3/20/2019)... ... March 20, 2019 , ... SmartLinx, ... Care Centre used its SmartLinx suite to refute a false allegation and immediately ... the Illinois Department of Public Health regulators alleged the facility was out of ...
(Date:3/19/2019)... ... March 19, 2019 , ... TreTap Launches First-Ever CBD Infused ... week online contest – One winner will receive TreTap beverages for a year ... CBD infused maple water beverage. Tretap, which was acquired by Vermont’s original CBD store ...
Breaking Medicine Technology:
Cached News: